1. Home
  2. OTLK vs TNDM Comparison

OTLK vs TNDM Comparison

Compare OTLK & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OTLK
  • TNDM
  • Stock Information
  • Founded
  • OTLK 2010
  • TNDM 2006
  • Country
  • OTLK United States
  • TNDM United States
  • Employees
  • OTLK N/A
  • TNDM 2650
  • Industry
  • OTLK Biotechnology: Biological Products (No Diagnostic Substances)
  • TNDM Medical/Dental Instruments
  • Sector
  • OTLK Health Care
  • TNDM Health Care
  • Exchange
  • OTLK Nasdaq
  • TNDM Nasdaq
  • Market Cap
  • OTLK N/A
  • TNDM 1.1B
  • IPO Year
  • OTLK 2016
  • TNDM 2013
  • Fundamental
  • Price
  • OTLK $1.45
  • TNDM $16.86
  • Analyst Decision
  • OTLK Strong Buy
  • TNDM Buy
  • Analyst Count
  • OTLK 5
  • TNDM 16
  • Target Price
  • OTLK $10.20
  • TNDM $44.44
  • AVG Volume (30 Days)
  • OTLK 448.0K
  • TNDM 1.5M
  • Earning Date
  • OTLK 05-14-2025
  • TNDM 04-30-2025
  • Dividend Yield
  • OTLK N/A
  • TNDM N/A
  • EPS Growth
  • OTLK N/A
  • TNDM N/A
  • EPS
  • OTLK N/A
  • TNDM N/A
  • Revenue
  • OTLK N/A
  • TNDM $940,203,000.00
  • Revenue This Year
  • OTLK N/A
  • TNDM $8.59
  • Revenue Next Year
  • OTLK $288.46
  • TNDM $10.87
  • P/E Ratio
  • OTLK N/A
  • TNDM N/A
  • Revenue Growth
  • OTLK N/A
  • TNDM 25.74
  • 52 Week Low
  • OTLK $0.87
  • TNDM $15.75
  • 52 Week High
  • OTLK $9.29
  • TNDM $53.69
  • Technical
  • Relative Strength Index (RSI)
  • OTLK 55.83
  • TNDM 33.57
  • Support Level
  • OTLK $1.30
  • TNDM $16.30
  • Resistance Level
  • OTLK $1.46
  • TNDM $17.73
  • Average True Range (ATR)
  • OTLK 0.13
  • TNDM 1.11
  • MACD
  • OTLK 0.04
  • TNDM 0.28
  • Stochastic Oscillator
  • OTLK 90.70
  • TNDM 29.92

About TNDM Tandem Diabetes Care Inc.

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Share on Social Networks: